홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic Acid → 2-{1-[3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoyl]piperidin-4-yl}-5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2,4-dihydro-3H-pyrazol-3-one

HRID 1914109
인쇄

반응식

HRID 1914109 반응식
Cl.[CH3:2][O:3][C:4]1[CH:5]=[C:6]([C:12]2[C:13]([CH3:25])([CH3:24])[C:14](=[O:23])[N:15]([CH:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)[N:16]=2)[CH:7]=[CH:8][C:9]=1[O:10][CH3:11].[CH:26]1([CH2:29][O:30][C:31]2[CH:32]=[C:33]([CH:37]=[CH:38][C:39]=2[O:40][CH:41]([F:43])[F:42])[C:34](O)=[O:35])[CH2:28][CH2:27]1>>[CH:26]1([CH2:29][O:30][C:31]2[CH:32]=[C:33]([CH:37]=[CH:38][C:39]=2[O:40][CH:41]([F:42])[F:43])[C:34]([N:20]2[CH2:21][CH2:22][CH:17]([N:15]3[C:14](=[O:23])[C:13]([CH3:25])([CH3:24])[C:12]([C:6]4[CH:7]=[CH:8][C:9]([O:10][CH3:11])=[C:4]([O:3][CH3:2])[CH:5]=4)=[N:16]3)[CH2:18][CH2:19]2)=[O:35])[CH2:28][CH2:27]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 23940063-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic AcidHCID 666164065-(3,4-dimethoxyphenyl)-4,4-dimethyl-2-piperidin-4-yl-2,4-dihydro-3H-pyrazol-3-one hydrochloride2회

생성물 1

HCID 462049622-{1-[3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoyl]piperidin-4-yl}-5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2,4-dihydro-3H-pyrazol-3-one

실험 절차

The title compound is prepared analogously as described for GP2-WU2 using 5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2-(piperidin-4-yl)-2,4-dihydro-3H-pyrazol-3-one (compound B1) and 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid as starting compounds. The crude product is purified by chromatography (amino phase silica gel and DCM) to yield the title compound.

후처리

  1. customThe title compound is prepared analogously
  2. customThe crude product is purified by chromatography (amino phase silica gel and DCM)

출처 및 근거

ORD 기록
ord-ec717490eae44783bd36d901e43f8fa8
출처 데이터셋
uspto-grants-2013_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08609848B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트